Breaking News Instant updates and real-time market news.

LULU

Lululemon

$183.86

-2.2 (-1.18%)

, NKE

Nike

$87.45

-0.59 (-0.67%)

07:24
07/11/19
07/11
07:24
07/11/19
07:24

Lululemon price target raised to $200 from $195 at Argus

Argus analyst John Staszak raised his price target on Lululemon (LULU) to $200 and kept his Buy rating, saying the company has "substantial opportunities" to expand outside North America, especially in the China market. The analyst is also positive on Lululemon's strong brand, growing e-commerce sales, and prospects in the apparel sector. Staszak notes that his new price target models a forward earnings multiple of 36-times, which is in the middle of the 22- to 44-times multiples of peers like Nike (NKE), Under Armour (UA), and VF Corp (VFC).

LULU

Lululemon

$183.86

-2.2 (-1.18%)

NKE

Nike

$87.45

-0.59 (-0.67%)

UA

Under Armour

$23.06

-0.145 (-0.63%)

VFC

VF Corp.

$86.85

0.11 (0.13%)

  • 16

    Jul

  • 24

    Jul

  • 24

    Jul

  • 25

    Sep

LULU Lululemon
$183.86

-2.2 (-1.18%)

07/02/19
BARD
07/02/19
NO CHANGE
Target $205
BARD
Outperform
Lululemon "newness" growth hits all-time high, says Baird
Baird analyst Mark Altschwager said his proprietary lululemon assortment tracker showed robust growth across total assortment. The survey showed its "Newness" growth hit historical highs driven by men's newness items. In addition, women's total assortment reached record highs and accelerated from May levels. Altschwager reiterated his Outperform rating and $205 price target on lululemon shares
06/13/19
NEED
06/13/19
NO CHANGE
NEED
Hold
Needham looking for better entry point on Lululemon
Needham analyst Rick Patel kept his Hold rating on Lululemon but said he is looking for a "better entry opportunity" on the stock after its "strong" Q1 results, saying the quarter marked a "continuation" of the company's execution across products, channels, and geographies. The analyst notes that although the magnitude of the earnings beat was relatively smaller, the results were "favorable" against the backdrop of a challenging retail environment. Patel believes that Lululemon can continue to generate strong comps, even though its gross margin expansion will slow as the company "laps significant product cost-related improvements."
06/14/19
BERN
06/14/19
NO CHANGE
BERN
Lululemon valuation can be sustained with SSS in double digits, says Bernstein
Bernstein analyst Jamie Merriman maintained 2019 EPS estimate of $4.62 following lululemon's Q1 results, and raised her 2020 EPS estimate to $5.60 due to stronger than expected direct to consumer growth in Q1 driving increased topline. In a research note to investors, Merriman says that while she believes lululemon's valuation can be sustained as long as total comp sales growth continues in the double digits, she struggles to find room for upside in the medium to long term.
07/09/19
DADA
07/09/19
NO CHANGE
Target $175
DADA
Neutral
Lululemon price target lowered to $175 from $180 at DA Davidson
DA Davidson analyst John Morris lowered his price target on Lululemon to $175 and kept his Neutral rating as part of his broader Davidson Datamining Dashboards report, saying its stock price has been moving higher in Q2 while the average price of its SKUs has been trending lower. The analyst also notes that up until this quarter, there was a strong correlation between those two lines, adding that the company's depth of markdowns has trended higher over the past year with the breadth of markdowns also being elevated since Q4. Morris contends that these trends suggest that Lululemon's pricing architecture has not been as robust as before, and its promotional occurence has become more regular.
NKE Nike
$87.45

-0.59 (-0.67%)

06/28/19
PIPR
06/28/19
NO CHANGE
Target $97
PIPR
Overweight
Piper remains buyer of Nike shares following Q4 results
Piper Jaffray analyst Erinn Murphy maintains an Overweight rating on shares of Nike with a $97 price target following last night's fiscal Q4 results. The analyst keeps her model largely unchanged and is pleased by Nike's sales growth of 10% constant currency, which was above guidance for high single digits. Murphy sees a "strong pipeline of catalysts," including the new JoyRide cushioning platform, SKNRS, Nike App, Olympics, and women's. She remains a buyer of the stock.
06/28/19
STFL
06/28/19
NO CHANGE
Target $96
STFL
Buy
Nike fundamental strength continued in Q4, says Stifel
Stifel analyst Jim Duffy says Nike's fiscal Q4 results last night featured continuation of its fundamental strength, including "still buoyant" trends in China and digital with notable strength from apps. The earnings call left the analyst more optimistic on Nike's near-term trends in China, momentum with digital platforms, and long-term margin opportunities from supply chain direction. He continues to view Nike as a "solid core holding" and reiterates his Buy rating and $96 price target on the shares.
06/28/19
BOFA
06/28/19
NO CHANGE
Target $70
BOFA
Underperform
BofA/Merrill lowers Nike estimates, maintains Underperform rating after earnings
BofA Merrill Lynch analyst Robert Ohmes lowered his Q1, FY20 and FY21 estimates for Nike following the company's Q4 report, stating that the company will be facing tough comparison in FY20 and he thinks wholesale and DTC could slow. The analyst, who said a deceleration in web traffic momentum heading into Back to School season implies the market could be facing another "Athletic Malaise" similar to 2017, keeps an Underperform rating and $70 price target on Nike shares.
06/28/19
MSCO
06/28/19
NO CHANGE
Target $103
MSCO
Overweight
Morgan Stanley says Nike investing from 'place of strength,' still a top pick
Morgan Stanley analyst Lauren Cassel said Nike management "shared many remarkable fiscal 2019 stats" on its Q4 earnings call, but the "most compelling" data points in her view include the fact that the company added $4B of incremental revenue in FY19 on a constant currency basis, that the DTC business drove about half of this incremental revenue growth and that digital sales grew by more than 35% year-over-year. Though its EPS missed estimates due to investments, Cassel sees Nike "investing from a place of strength and believes its underlying revenue and gross margin drivers are still "impressive." She keeps an Overweight rating and $103 price target on Nike shares and continues to identify the stock as her top pick.
UA Under Armour
$23.06

-0.145 (-0.63%)

05/17/19
JPMS
05/17/19
UPGRADE
Target $29
JPMS
Overweight
Under Armour upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Matthew Boss upgraded Under Armour to Overweight from Neutral and raised his price target for the shares to $29 from $23.
06/27/19
GSCO
06/27/19
DOWNGRADE
Target $30
GSCO
Sell
Goldman downgrades Nordstrom to Sell, cuts price target to $30 from $37
Goldman Sachs analyst Alexandra Walvis downgraded Nordstrom (JWN) to Sell from Neutral and lowered her price target for the shares to $30 from $37. The analyst is taking a "conservative stance" on the retail sector. The headwinds in Q2 have proven persistent, says the analyst, who sees risk that a second half of the year inflection in earnings growth may not materialize for many companies. Walvis recommends a selective approach in Apparel and prefers stocks with "clear" second half catalysts or strategic actions to drive momentum. She reiterates Buy ratings on both Under Armour (UAA) and Tapestry (TPR) and downgraded both Nordstrom and Ross Stores (ROST) to Sell. She believes Nordstrom's ongoing "comp headwinds" in full line and off price stores are compounded by its ongoing strategic investments and the opening of the company's flagship in New York City.
05/17/19
05/17/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she views Foot Locker as a "best-in-class" footwear retailer and sees an attractive entry point at current valuation levels. 2. Under Armour (UA, UAA) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss citing his meeting with management, including CEO Kevin Plank, and saying the clear tone from the top was "controlled confidence" in the brand direction with "disciplined" fiscal 2020 global top- and bottom-line growth acceleration. 3. Philip Morris (PM) upgraded to Neutral from Underperform at BofA/Merrill with analyst Lisa Lewandowski saying IQOS, the company's heated tobacco product, is gaining traction in several European and Asian markets, the FDA approved the pre-market application for the sale of IQOS in the U.S., and management has reset IQOS commercialization expectations, among other reasons. 4. Walmart (WMT) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying he believes the company's EBIT gains in the U.S. will continue. 5. United Therapeutics (UTHR) upgraded to Neutral from Sell at UBS with analyst Carter Gould saying that after a 26% stock price decline since late March, when Sandoz launched generic Remodulin, the risk reward on the stock has become more balanced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/19
JPMS
05/17/19
UPGRADE
Target $29
JPMS
Overweight
JPMorgan upgrades Under Armour to Overweight with $29 price target
JPMorgan analyst Matthew Boss upgraded Under Armour to Overweight from Neutral and raised his price target for the shares to $29 from $23. The shares closed yesterday up 52c to $21.88. After meeting with management including CEO Kevin Plank, Boss says the clear tone from the top was "controlled confidence" in the brand direction with "disciplined" fiscal 2020 global top- and bottom-line growth acceleration. This will be driven by the combination of product, innovation, and marketing after management's three-year strategic "shrink phase" completed exiting fiscal 2019, Boss tells investors in a research note. He believes this translates into a favorable multi-year risk/reward on shares of Under Armour.
VFC VF Corp.
$86.85

0.11 (0.13%)

06/27/19
COWN
06/27/19
NO CHANGE
Target $100
COWN
Outperform
VF Corp. price target raised to $100 from $90 at Cowen
Cowen analyst John Kernan raised his price target on VF Corp. to $100 from $90 as he believes sales and earnings guidance are conservative. He sees the September investor day as a potential catalyst as the company should lay out new five-year targets, which should be positive for the shares. Kernan reiterated his Outperform rating on VF Corp. shares.
05/17/19
05/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twitter (TWTR) initiated with an Equal Weight at Consumer Edge. 2. Wayfair (W) initiated with a Buy at Jefferies. 3. Kontoor Brands (KTB) initiated with a Neutral at Goldman Sachs whyle VF Corp. (VFC) post-spin shares were initiated with Buy at Goldman Sachs. 4. Kimbell Royalty Partners (KRP) initiated with a Buy at UBS. 5. Concrete Pumping (BBCP) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/19
GUGG
05/24/19
NO CHANGE
Target $95
GUGG
Buy
VF Corp. price target raised to $95 from $90 at Guggenheim
Guggenheim analyst Robert Drbul raised his price target on VF Corp. shares to $95 from $90 following the company's Q4 report, noting that its three largest brands grew a combined 9%, or 13% in constant currency. He believes the company's "acute focus" on high margin channels, such as direct-to-consumer, digital and international, position it well to drive healthy long-term growth in revenue and margins. Drbul keeps a Buy rating on VF Corp. shares.
05/28/19
STFL
05/28/19
INITIATION
Target $46
STFL
Buy
Kontoor Brands initiated with a Buy at Stifel
Stifel analyst Jim Duffy started Kontoor Brands (KTB) with a Buy rating and $46 price target, telling investors that he is constructive on its "strong foundational position" in the Jeanswear market, relative valuation and the potential of growth and margin surprises. The recent spinoff from VF Corporation (VFC) has "Consumer Staple like business qualities," but with superior free cash flow and a 6%+ dividend yield that is unique in the apparel category, said Duffy.

TODAY'S FREE FLY STORIES

INAP

Internap

$3.56

0.13 (3.79%)

16:22
07/16/19
07/16
16:22
07/16/19
16:22
Hot Stocks
Internap to streamline organization, initiates search for new CFO »

Internap announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

Fidelity National

$41.57

0.02 (0.05%)

16:21
07/16/19
07/16
16:21
07/16/19
16:21
Earnings
Fidelity National reports Q2 adjusted EPS 92c, consensus 87c »

Reports Q2 revenue $2.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 01

    Aug

  • 13

    Nov

RM

Regional Management

$26.62

-0.28 (-1.04%)

16:20
07/16/19
07/16
16:20
07/16/19
16:20
Hot Stocks
Regional Management appoints Robert Beck CFO »

Regional Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
07/16/19
07/16
16:20
07/16/19
16:20
Options
Closing CBOE SPX and VIX Index summary for July 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$15.54

-0.65 (-4.01%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
Whiting Petroleum names Correne S. Loeffler CFO »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 27

    Aug

UAL

United Continental

$94.00

2.7 (2.96%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
Breaking Hot Stocks news story on CSX »

CSX Q2 CapEx down to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

BPMX

BioPharmX

$0.44

-0.0183 (-3.97%)

16:19
07/16/19
07/16
16:19
07/16/19
16:19
Hot Stocks
BioPharmX appoints Steven Bosacki COO »

BioPharmX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCCL

China Ceramics

$0.87

(0.00%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
China Ceramics receives Nasdaq notification of non-compliance »

China Ceramics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$94.00

2.7 (2.96%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
United Continental reports Q2 total passenger revenue up 6.1% y/y »

Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

VNDA

Vanda Pharmaceuticals

$13.45

-0.13 (-0.96%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
Vanda Pharmaceuticals announces study results for tradipitant »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

STIM

Neuronetics

$12.65

-0.2 (-1.56%)

, UNH

UnitedHealth

$264.60

-1.31 (-0.49%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Recommendations
Neuronetics, UnitedHealth analyst commentary  »

UnitedHealth coverage…

STIM

Neuronetics

$12.65

-0.2 (-1.56%)

UNH

UnitedHealth

$264.60

-1.31 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CTAS

Cintas

$239.46

-3.85 (-1.58%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Earnings
Cintas sees FY20 EPS $8.30-$8.45, consensus $8.32 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

UAL

United Continental

$94.00

2.7 (2.96%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Earnings
United Continental raises FY19 adj. EPS view to $10.50-$12.00, consensus $11.33 »

Prior view was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$239.46

-3.85 (-1.58%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Earnings
Cintas reports Q4 EPS ex-items $2.07, consensus $1.93 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Hot Stocks
CSX says merchandise growth 'offset' intermodal weakness »

Chemicals increased as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

PETX

Aratana Therapeutics

$4.94

-0.11 (-2.18%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Hot Stocks
Aratana Therapeutics shareholders vote to adopt merger with Elanco Animal Health »

Aratana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$94.00

2.7 (2.96%)

16:15
07/16/19
07/16
16:15
07/16/19
16:15
Earnings
United Continental reports Q2 adjusted EPS $4.21, consensus $4.08 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

KSFTF

Kingsoft

$0.00

(0.00%)

16:15
07/16/19
07/16
16:15
07/16/19
16:15
Downgrade
Kingsoft rating change  »

Kingsoft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$79.68

1.16 (1.48%)

16:13
07/16/19
07/16
16:13
07/16/19
16:13
Hot Stocks
CSX reports Q2 operating ratio fell to 57.4% since Q2 last year »

Last year's Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

PDD

Pinduoduo

$20.13

0.77 (3.98%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Downgrade
Pinduoduo rating change  »

Pinduoduo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$62.76

0.13 (0.21%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Earnings
Nicolet Bankshares reports Q1 EPS $1.91 with items, consensus $1.09 »

During Q2, Nicolet sold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$41.65

-1.39 (-3.23%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Downgrade
Weibo rating change  »

Weibo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.